Skip to main content

Table 1 Background characteristics of the patients with vascular dementia (VD) ( X ¯ ± s )

From: Quantitative evaluation of severity of behavioral and psychological symptoms of dementia in patients with vascular dementia

Characteristic

Number

1st week

24th week

Age (years)

 

60.2 ± 9.7

Sex (M/F)

 

39/17

Duration of VD (years)

 

6.9 ± 5.2

MMSE

 

12.1 ± 1.7

10.9 ± 1.6

Huperzine A (μg/d)

n = 24

323.30 ± 173.9

358.30 ± 191.4

Aniracetam (mg/d)

n = 26

489.6 ± 179.3

506.6 ± 108.7

Memantine Hydrochloride (mg/d)

n = 30

6.67 ± 5.38

6.98 ± 4.47

 Donepezil Hydrochloride (mg/d)

n = 16

8.21 ± 3.76

9.33 ± 6.94

 Rivastigmine (mg/d)

n = 13

3.33 ± 1.66

3.75 ± 1.66

Galantamine Reminyl (mg/d)

n = 16

25.65 ± 22.36

26.82 ± 22.91

  1. MMSE indicates Mini–mental state examination. Cognitive function drug administration: 1 class of drug 73.2%; 2 classes 23.6%; 3 classes 3.2%.